Drug skin tests and systemic cutaneous adverse drug reactions: an update

References

• Barbaud A. Drug patch testing in systemic cutaneous drug allergy. Toxicology209, 209–216 (2005).
   PubMed Web of Science ®Google Scholar
• Barbaud A, Reichert-Penetrat S, Trechot P et al. The use of skin testing in the investigation of cutaneous adverse drug reactions. Br. J. Dermatol.139, 49–58 (1998).
   PubMed Web of Science ®Google Scholar
• Barbaud A, Gonçalo M, Bruynzeel D, Bircher A. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Dermatitis45, 321–328 (2001).
   PubMed Web of Science ®Google Scholar
• Barbaud A, Bene MC, Faure G, Schmutz JL. Tests cutanés dans l’exploration des toxidermies supposées de mécanisme immuno-allergique. Bull. Acad. Natl Med.184, 47–63 (2000).
   Google Scholar
• Osawa J, Naito S, Aihara M, Kitamura K, Ikezawa Z, Nakajima H. Evaluation of skin test reactions in patients with non-immediate type drug eruptions. J. Dermatol.17, 235–239 (1990).
   PubMedGoogle Scholar
• Bruynzeel DP, Van Ketel WG. Patch testing in drug eruptions. Semin. Dermatol.8, 196–203 (1989).
   Google Scholar
• Barbaud A. Tests cutanés dans l’investigation des toxidermies: de la physiopathologie aux résultats des investigations. Therapie57, 258–262 (2002).
   Google Scholar
• Alanko K, Stubb S, Reitamo S. Topical provocation of fixed drug eruption. Br. J. Dermatol.116, 561–567 (1987).
   PubMedGoogle Scholar
• Bruynzeel DP, Van Ketel WG. Skin tests in the diagnosis of maculopapular drug eruptions. Semin. Dermatol.6, 119–124 (1987).
   Google Scholar
• Romano A, Di Fonso M, Pietrantonio F et al. Repeated patch testing in delayed hypersensitivity to β-lactam antibiotics. Contact Dermatitis28, 190 (1993).
   Google Scholar
• Barbaud A, Bene MC, Schmutz JL, Ehlinger A, Weber M, Faure GC. Role of delayed cellular hypersensitivity and adhesion molecules in maculopapular rashes induced by amoxicillin. Arch. Dermatol.133, 481–486 (1997).
   PubMedGoogle Scholar
• Fernandez T, Torres MJ, R-Pena R et al. Decrease of selective immunoglobulin E response to amoxicillin despite repeated administration of benzylpenicillin and penicillin V. Clin. Exp. Allergy35, 1645–1650 (2005).
   Google Scholar
• Britschgi M, Steiner UC, Schmid S et al. T-cell involvement in drug-induced acute generalized exanthematous pustulosis. J. Clin. Invest.107, 1433–1441 (2001).
   PubMed Web of Science ®Google Scholar
• Felix RH, Comaish JS. The value of the patch tests and other skin tests in drug eruptions. Lancet1, 1017–1019 (1974).
   Google Scholar
• Brockow K, Romano A, Blanca M, Ring J, Pichler W, Demoly P. General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy57, 45–51 (2002).
   PubMed Web of Science ®Google Scholar
• Wolkenstein P, Chosidow O, Flechet M-L et al. Patch testing in severe cutaneous adverse drug reactions, including Stevens–Johnson syndrome and toxic epidermal necrolysis. Contact Dermatitis35, 234–236 (1996).
   PubMed Web of Science ®Google Scholar
• Kleinhans M, Linzbach L, Zedlitz S, Kaufmann R, Boehncke WH. Positive patch test reactions to celecoxib may be due to irritation and do not correlate with the results of oral provocation. Contact Dermatitis47, 100–102 (2002).
   PubMedGoogle Scholar
• Barbaud A, Bursztejn AC, Vernassiere C, Schmutz JL. Trechot Ph. Toxidermie à l’Aerius®: les patch-tests avec la desloratadine induisent des faux positifs. Ann. Dermatol. Vénéréol.132, s71 (2005).
   Google Scholar
• Barbaud A, Trechot P, Reichert-Penetrat S, Commun N, Schmutz JL. Relevance of skin tests with drugs in investigating cutaneous adverse drug reactions. Contact Dermatitis45, 265–268 (2001).
   Google Scholar
• Conilleau V, Dompmartin A, Michel M, Verneuil L, Leroy D. Photoscratch testing in systemic drug-induced photosensitivity. Photodermatol. Photoimmunol. Photomed.16, 62–66 (2000).
   Google Scholar
• Lammintausta K, Mäkela L, Kalimo K. Rapid systemic valaciclovir reaction subsequent to aciclovir contact. Allergy Contact Dermatitis45, 181 (2001).
   Google Scholar
• Ozkaya-Bayazit E, Bayazit H, Ozarmagan G. Topical provocation in 27 cases of cotrimoxazole-induced fixed drug eruption. Contact Dermatitis41, 185–189 (1999).
   Google Scholar
• Klein CE, Trautmann A, Zillikens D, Brocker EB. Patch testing in an unusual case of toxic epidermal necrolysis. Contact Dermatitis33, 448–449 (1995).
   Google Scholar
• Barbaud A, Trechot P, Reichert-Penetrat S, Granel F, Schmutz JL. Drug patch testing: the usefulness in testing on the most previously affected site in a systemic cutaneous adverse drug reaction to tetrazepam. Contact Dermatitis44, 259–260 (2001).
   PubMed Web of Science ®Google Scholar
• Wilkinson DS, Fregert S, Magnusson B et al. Terminology of contact dermatitis. Acta Dermatovenereol. (Stockholm)50, 287–292 (1970).
   PubMed Web of Science ®Google Scholar
• Jonker MJ, Bruynzeel D. Anaphylactic reaction elicited by patch testing with diclofenac. Contact Dermatitis49, 114–115 (2003).
   Google Scholar
• Romano A, Guéant-Rodriguez RM, Viola M et al. Diagnosing immediate reactions to cephalosporins. Clin. Exp. Allergy35(9), 1234–1242 (2005).
   PubMed Web of Science ®Google Scholar
• Co Minh HB, Bousquet PJ, Fontaine C, Kvedariene V, Demoly P. Systemic reactions during skin tests with β-lactams: a risk factor analysis. J. Allergy Clin. Immunol.117, 466–448 (2006).
   PubMed Web of Science ®Google Scholar
• Laxenaire MC, Moneret-Vautrin DA. Anaphylactic reactions to rocuronium. Br. J. Anaesth.85, 325–326 (2000).
   Google Scholar
• Torres M-J, Sanchez-Sabate E, Alvarez J et al. Skin test evaluation in nonimmediate allergic reactions to penicillins. Allergy59, 219–224 (2004).
   PubMed Web of Science ®Google Scholar
• Rodriguez-Bada JL, Montanez MI, Torres MJ et al. Skin testing for immediate hypersensitivity to betalactams: comparison between two commercial kits. Allergy61, 947–951 (2006).
   PubMedGoogle Scholar
• Antunez C, Blanca-Lopez N, Torres MJ et al. Immediate allergic reactions to cephalosporins: evaluation of cross-reactivity with a panel of penicillins and cephalosporins. J. Allergy Clin. Immunol.117, 404–410 (2006).
   PubMed Web of Science ®Google Scholar
• Lammintausta K, Kortekangas-Savolainen O. The usefulness of skin tests to prove drug hypersensitivity. Br. J. Dermatol.152, 968–974 (2005).
   PubMedGoogle Scholar
• Romano A, Viola M, Mondino C et al. Diagnosing nonimmediate reactions to penicillins by in vivo tests. Int. Arch. Allergy Immunol.129, 169–174 (2002).
   PubMed Web of Science ®Google Scholar
• Bernedo N, Gonzalez I, Gastaminza G, Audicana M, Fernandez E, Munoz D. Positive patch test in vancomycin allergy. Contact Dermatitis45, 43 (2001).
   Google Scholar
• Hausermann P, Harr T, Bircher AJ. Baboon syndrome resulting from systemic drugs: is there strife between SDRIFE and allergic contact dermatitis syndrome? Contact Dermatitis51, 297–310 (2004).
   PubMed Web of Science ®Google Scholar
• Romano A, Di Fonso M, Papa G et al. Evaluation of adverse cutaneous reactions to aminopenicillins with emphasis on those manifested by maculopapular rashes. Allergy50, 113–118 (1995).
   PubMed Web of Science ®Google Scholar
• Barbaud A, Trechot P, Weber-Muller F, Ulrich G, Commun N, Schmutz JL. Drug skin tests in cutaneous adverse drug reactions to pristinamycin: 29 cases with a study of cross-reactions between synergistins. Contact Dermatitis50, 22–26 (2004).
   Google Scholar
• Menczer J, Barda G, Glezerman M et al. Hypersensitivity reaction to carboplatin. Results of skin tests. Eur. J. Gynaecol. Oncol.20, 214–216 (1999).
   Google Scholar
• Markman M, Zanotti K, Peterson G, Kulp B, Webster K, Belinson J. Expanded experience with an intradermal skin test to predict for the presence or absence of carboplatin hypersensitivity. J. Clin. Oncol.21, 4611–4614 (2003).
   PubMed Web of Science ®Google Scholar
• Leguy-Seguin V, Jolimoy G, Coudert B et al. Diagnostic and predictive value of skin testing in platinum salts hypersensitivity. J. Allergy Clin. Immunol.119, 726–730 (2007).
   PubMed Web of Science ®Google Scholar
• Brockow K, Becker EW, Worret WI, Ring J. Late skin test reactions to radiocontrast medium. J. Allergy Clin. Immunol.104, 1107–1108 (1999).
   Google Scholar
• Vernassiere C, Trechot P, Schmutz JL, Barbaud A. Results and negative value of skin tests in investigating delayed reactions to radio-contrast media. Contact Dermatitis50, 359–366 (2004).
   Google Scholar
• Brockow K, Christiansen C, Kanny G et al.; ENDA; EAACI interest group on drug hypersensitivity. Management of hypersensitivity reactions to iodinated contrast media. Allergy60, 150–158 (2005).
   PubMed Web of Science ®Google Scholar
• Gueant-Rodriguez RM, Romano A, Barbaud A, Brockow K, Gueant JL. Hypersensitivity reactions to iodinated contrast media. Curr. Pharm. Des.12, 3359–3372 (2006).
   PubMed Web of Science ®Google Scholar
• Bircher AJ, Harr T, Hohenstein L, Tsakiris DA. Hypersensitivity reactions to anticoagulant drugs: diagnosis and management options. Allergy61, 1432–1440 (2006).
   PubMed Web of Science ®Google Scholar
• Ludwig RJ, Beier C, Lindhoff-Last E, Kaufmann R, Boehncke WH. Tolerance of fondaparinux in a patient allergic to heparins and other glycosaminoglycans. Contact Dermatitis49, 158–159 (2003).
   PubMed Web of Science ®Google Scholar
• Romano A, Viola M, Mondino C et al. Diagnosing nonimmediate reactions to penicillins by in vivo tests. Int. Arch. Allergy Immunol.129, 169–174 (2002).
   PubMed Web of Science ®Google Scholar
• Kilpio K, Hannuksela M. Corticosteroid allergy in asthma. Allergy58, 1131–1135 (2003).
   Google Scholar
• Buettiker U, Keller M, Pichler WJ, Braathen LR, Yawalkar N. Oral prednisolone induced acute generalized exanthematous pustulosis due to corticosteroids of group A confirmed by epicutaneous testing and lymphocyte transformation tests. Dermatology213, 40–43 (2006).
   Google Scholar
• Lee AY, Choi J, Chey WY. Patch testing with carbamazepine and its main metabolite carbamazepine epoxide in cutaneous adverse drug reactions to carbamazepine. Contact Dermatitis48, 137–139 (2003).
   PubMed Web of Science ®Google Scholar
• Cholez C, Trechot P, Schmutz JL, Faure G, Bene MC, Barbaud A. Maculopapular rash induced by diltiazem: allergological investigations in four patients and cross reactions between calcium channel blockers. Allergy58, 1207–1209 (2003).
   Google Scholar
• Sanchez TS, Sanchez-Perez J, Aragues M, Garcia-Diaz A. Flare-up reaction of pseudoephedrine baboon syndrome after positive patch test. Contact Dermatitis42, 312–313 (2000).
   PubMed Web of Science ®Google Scholar
• Pirker C, Misic A, Brinkmeier T, Frosch PJ. Tetrazepam drug sensitivity – usefulness of the patch test. Contact Dermatitis47, 135–138 (2002).
   PubMed Web of Science ®Google Scholar
• Akiyama M, Nakada T, Sueki H, Fujisawa R, Iijima M. Drug eruption caused by non-ionic iodinated X-ray contrast media. J. Acad. Radiol.5, s159–s161 (1998).
   Google Scholar
• Vernassiere C, Barbaud A, Trechot PH, Weber-Muller F, Schmutz JL. Systemic acyclovir reaction subsequent to acyclovir contact allergy: which systemic antiviral drug should then be used? Contact Dermatitis49, 155–157 (2003).
   Google Scholar
• Sakakibara T, Hata M, Numano K et al. Fixed-drug eruption caused by allylisopropylacetylurea. Contact Dermatitis44, 189–190 (2001).
   Google Scholar
• Gaig P, San Miguel-Moncin MM, Bartra J, Bonet A, Garcia-Ortega P. Usefulness of patch tests for diagnosing selective allergy to captopril. J. Investig. Allergol. Clin. Immunol.11, 204–206 (2001).
   Google Scholar
• Kawada A, Aragane Y, Maeda A, Asai M, Shiraishi H, Tezuka T. Drug eruption induced by cefcapene pivoxil hydrochloride. Contact Dermatitis44, 197 (2001).
   Google Scholar
• Verbeiren S, Morant C, Charlanne H, Ajebbar K, Caron J, Modiano P. Toxidermie due au celecoxib avec tests épicutané positif. Ann. Dermatol. Venereol.129, 203–205 (2002).
   Google Scholar
• Machet L, Vaillant L, Dardaine V, Lorette G. Patch testing with clobazam: relapse of generalized drug eruption. Contact Dermatitis26, 347–348 (1992).
   Google Scholar
• Brown VL, Orton DI. Cutaneous adverse drug reaction to oral chlorphenamine detected with patch testing. Contact Dermatitis52, 49–50 (2005).
   Google Scholar
• Estrada JL, Alvarez Puebla MJ, Ortiz de Urbina JJ, Matilla B, Prieto MA, Gozalo F. Generalized eczema due to codeine. Contact Dermatitis44, 185 (2001).
   Google Scholar
• Frouin E, Roth B, Grange A, Grange F, Tortel MC, Guillaume JC. Syndrome d'hypersensibilité à la fluindione (Préviscan®). Positivité des tests épicutanés. Ann. Dermatol. Venereol.132, 1000–1002 (2005).
   Google Scholar
• Rodriguez-Morales A, Alonso Llamazares A, Palacios Benito R, Martinez Cocera C. Fixed drug eruption from quinolones with a positive lesional patch test to ciprofloxacin. Contact Dermatitis44, 255 (2001).
   Google Scholar
• Scherer K, Bircher AJ. Hypersensitivity reactions to fluoroquinolones. Curr. Allergy Asthma Rep.5, 15–21 (2005).
   PubMed Web of Science ®Google Scholar
• Schmid DA, Depta JP, Pichler WJ. T cell-mediated hypersensitivity to quinolones: mechanisms and cross-reactivity. Clin. Exp. Allergy36, 59–69 (2006).
   PubMed Web of Science ®Google Scholar
• Rebello S, Sanchez P, Vega JM et al. Hypersensitivity syndrome from isoniazid with positive patch test. Contact Dermatitis45, 306 (2001).
   Google Scholar
• Gonzalo-Garijo MA, de Arila D, Rodriguez-Nevado I. Generalized reaction after patch testing with metamizol. Contact Dermatitis45, 180 (2001).
   Google Scholar
• Quinones Estevez D, Fernandez Schmitz C. Exanthema to metamizole. Allergy56, 262–263 (2001).
   Google Scholar
• Sasaki K, Yamamoto T, Kishi M, Yokozeki H, Nishioka K. Acute exanthematous pustular drug eruption induced by mexiletine. Eur. J. Dermatol.11, 469–471 (2001).
   Google Scholar
• Antunes A, Davril A, Trechot P, Grandidier M, Truchetet F, Cuny JF. Syndrome d’hypersensibilité à la minocycline. Ann. Dermatol. Venereol.126, 518–521 (1999).
   Google Scholar
• Grange-Prunier A, Roth B, Kleinclaus I, Fagot JP, Guillaume JC. Pustulose exanthématique aigue generalisee due au carbimazole (Neomercazole): premier cas et valeur des patch tests. Ann. Dermatol. Venereol.133, 708–710 (2006).
   Google Scholar
• Malheiro D, Cadinha S, Rodrigues J, Vaz M, Castel-Branco MG. Nimesulide-induced fixed drug eruption. Allergol. Immunopathol. (Madr.)33, 285–287 (2005).
   Google Scholar
• Barranco R, Tornero P, De Barrio M, De Frutos C, Rodriguez A, Rubio M. Type IV hypersensitivity to oral nystatin. Contact Dermatitis45, 60 (2001).
   Google Scholar
• Mashiah J, Brenner S. A systemic reaction to patch testing for the evaluation of acute generalized exanthematous pustulosis. Arch. Dermatol.139, 1181–1183 (2003).
   PubMed Web of Science ®Google Scholar
• Montoro J, Diaz M, Genis C, Lozano A, Bertomeu F. Non-pigmenting cutaneous-mucosal fixed drug eruption due to piroxicam. Allergol. Immunopathol.31, 53–55 (2003).
   Google Scholar
• Wong DA, Freeman S. Cutaneous allergic reaction to intramuscular vitamin K1. Australas. J. Dermatol.40, 147–152 (1999).
   PubMedGoogle Scholar
• Antunez C, Martin E, Cornejo-Garcia JA et al. Immediate hypersensitivity reactions to penicillins and other β-lactams. Curr. Pharm. Des.12, 3327–3333 (2006).
   PubMed Web of Science ®Google Scholar
• Bonadonna P, Schiappoli M, Senna G, Passalacqua G. Delayed selective reaction to clavulanic acid: a case report. J. Investig. Allergol. Clin. Immunol.15, 302–304 (2005).
   Google Scholar
• Torres MJ, Romano A, Mayorga C et al. Diagnostic evaluation of a large group of patients with immediate allergy to penicillins: the role of skin testing. Allergy56, 850–856 (2001).
   PubMed Web of Science ®Google Scholar
• AEl-Qutob D, Morales C, Pelaez A. Allergic reaction caused by articaine. Allergol. Immunopathol. (Madr.)33, 115–116 (2005).
   Google Scholar
• Berkun Y, Ben-Zvi A, Levy Y, Galili D, Shalit M. Evaluation of adverse reactions to local anesthetics: experience with 236 patients. Ann. Allergy Asthma Immunol.91, 342–345 (2003).
   Google Scholar
• Herrero T, Tornero P, Infante S et al. Diagnosis and management of hypersensitivity reactions caused by oxaliplatin. J. Investig. Allergol. Clin. Immunol.16, 327–330 (2006).
   PubMed Web of Science ®Google Scholar
• Notman MJ, Phillips EJ, Knowles SR, Weber EA, Shear NH. Clindamycin skin testing has limited diagnostic potential. Contact Dermatitis.53, 335–338 (2005).
   PubMedGoogle Scholar
• Padial A, Posadas S, Alvarez J et al. Nonimmediate reactions to systemic corticosteroids suggest an immunological mechanism. Allergy60, 665–670 (2005).
   Google Scholar
• Venturini M, Lobera T, del Pozo MD, González I, Blasco A. Immediate hypersensitivity to corticosteroids. J. Investig. Allergol. Clin. Immunol.16, 51–56 (2006).
   Google Scholar
• Caceres Calle O, Fernandez-Benitez M. Allergy to dexchlorpheniramine. Study of a case. Allergol. Immunopathol. (Madr.)32, 306–309 (2004).
   Google Scholar
• Beaudouin E, Kanny G, Blanloeil Y, Guilloux L, Renaudin JM, Moneret-Vautrin DA. Anaphylactic shock induced by gadoterate meglumine (DOTAREM). Allerg. Immunol. (Paris)35, 382–385 (2003).
   Google Scholar
• Jappe U, Juschka U, Kuner N, Hausen BM, Krohn K. Fondaparinux: a suitable alternative in cases of delayed-type allergy to heparins and semisynthetic heparinoids? A study of 7 cases. Contact Dermatitis51, 67–72 (2004).
   PubMed Web of Science ®Google Scholar
• Ludwig RJ, Schindewolf M, Alban S, Kaufmann R, Lindhoff-Last E, Boehncke WH. Molecular weight determines the frequency of delayed type hypersensitivity reactions to heparin and synthetic oligosaccharides. Thromb. Haemost.94, 1265–1269 (2005).
   PubMed Web of Science ®Google Scholar
• Ludwig RJ, Schindewolf M, Utikal J, Lindhoff-Last E, Boehncke WH. Management of cutaneous type IV hypersensitivity reactions induced by heparin. Thromb. Haemost.96, 611–617 (2006).
   PubMed Web of Science ®Google Scholar
• Gerhardt A, Zotz RB, Stockschlaeder M, Scharf RE. Fondaparinux is an effective alternative anticoagulant in pregnant women with high risk of venous thromboembolism and intolerance to low-molecular-weight heparins and heparinoids. Thromb. Haemost.97, 496–467 (2007).
   PubMed Web of Science ®Google Scholar
• Adachi A, Fukunaga A, Horikawa T. A case of human insulin allergy induced by short-acting and intermediate-acting insulin but not by long-acting insulin. Int. J. Dermatol.43, 597–599 (2004).
   Google Scholar
• Lee AY, Chey WY, Choi J, Jeon JS. Insulin-induced drug eruptions and reliability of skin tests. Acta Derm. Venereol.82, 114–117 (2002).
   Google Scholar
• Takahama H, Tsutsumi Y, Kubota Y. Anaphylaxis due to levofloxacin. Int. J. Dermatol.44, 789–790 (2005).
   Google Scholar
• Buergin S, Scherer K, Hausermann P, Bircher AJ. Immediate hypersensitivity to rifampicin in 3 patients: diagnostic procedures and induction of clinical tolerance. Int. Arch. Allergy Immunol.140, 20–26 (2006).
   Web of Science ®Google Scholar
• Strauss RM, Green ST, Gawkrodger DJ. Rifampicin allergy confirmed by an intradermal test, but with a negative patch test. Contact Dermatitis45, 108 (2001).
   Google Scholar
• Patel VJ, Bruck MC, Katz BE. Hypersensitivity reaction to hyaluronic acid with negative skin testing. Plast. Reconstr. Surg.117, 92e–94e (2006).
   Web of Science ®Google Scholar
• Fays S, Trechot P, Schmutz JL, Cuny JF, Truchetet F, Barbaud A. Bupropion and generalized acute urticaria: eight cases. Br. J. Dermatol.148, 177–178 (2003).
   PubMed Web of Science ®Google Scholar
• Trujillo MJ, de Barrio M, Rodriguez A et al. Piroxicam-induced photodermatitis. Cross-reactivity among oxicams. A case report. Allergol. Immunopathol. (Madr.)29, 133–136 (2001).
   Google Scholar
• Gonçalo M, Figueiredo A. Cross-reactions among oxicams in cutaneous adverse drug reactions. Contact Dermatitis46, s31 (2002).
   Google Scholar
• Barranco R, Rodriguez A, de Barrio M et al. Sympathomimetic drug allergy: cross-reactivity study by patch test. Am. J. Clin. Dermatol.5, 351–355 (2004).
   Google Scholar
• Romano A, Pettinato R, Andriolo M et al. Hypersensitivity to aromatic anticonvulsants: in vivo and in vitro cross-reactivity studies. Curr. Pharm. Des.12, 3373–3381 (2006).
   Google Scholar
• Viola M, Quaratino D, Gaeta F et al. Celecoxib tolerability in patients with hypersensitivity (mainly cutaneous reactions) to nonsteroidal anti-inflammatory drugs. Int. Arch. Allergy Immunol.137, 145–150 (2005).
   Google Scholar
• Sondhi D, Lippmann M, Murali G. Airway compromise due to angiotensin-converting enzyme inhibitor-induced angioedema: clinical experience at a large community teaching hospital. Chest126, 400–404 (2004).
   PubMed Web of Science ®Google Scholar
• Van Rijnsoever EW, Kwee-Zuiderwijk WJ, Feenstra J. Angioneurotic edema attributed to the use of losartan. Arch. Intern. Med.158, 2063–2065 (1998).
   PubMed Web of Science ®Google Scholar
• Mohaupt MG, Vogt B, Frey FJ. Sirolimus-associated eyelid edema in kidney transplant recipients. Transplantation72, 162–164 (2001).
   Google Scholar
• Maalouf T, Angioi K, Champigneulle J, Guerci A, George JL. Oedeme palpebral secondaire a un traitement par un inhibiteur de tyrosine kinase (Glivec). A propos d’un cas. J. Fr. Ophtalmol.27, 107–109 (2004).
   Google Scholar
• Esmaeli B, Prieto VG, Butler CE et al. Severe periorbital edema secondary to STI571 (Gleevec). Cancer95, 881–887 (2002).
   PubMed Web of Science ®Google Scholar
• Zink M, Kuwilsky A, Knopf U. Olanzapine-associated bilateral eyelid edema. J. Clin. Psychopharmacol.27, 214–215 (2007).
   Web of Science ®Google Scholar
• Chandeclerc ML, Martin S, Petitpain N, Barbaud A, Schmutz JL. Tadalafil and palpebral edema. South Med. J.97, 1142–1143 (2004).
   Google Scholar
• Romano A, Quaratino D, Papa G, Di Fonso M, Venuti A. Aminopenicillin allergy. Arch. Dis. Child.76, 513–517 (1997).
   PubMed Web of Science ®Google Scholar
• Torres MJ, Mayorga C, Leyva L et al. Controlled administration of penicillin to patients with a positive history but negative skin and specific serum IgE tests. Clin. Exp. Allergy32, 270–276 (2002).
   PubMed Web of Science ®Google Scholar
• Messaad D, Sahla H, Benahmed S, Godard P, Bousquet J, Demoly P. Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction. Ann. Intern. Med.140, 1001–1006 (2004).
   PubMed Web of Science ®Google Scholar
• Ponvert C, Weilenmann C, Wassenberg J et al. Allergy to betalactam antibiotics in children: a prospective follow-up study in retreated children after negative responses in skin and challenge tests. Allergy62, 42–46 (2007).
   PubMed Web of Science ®Google Scholar
• Demoly P, Benahmed S, Sahla H et al. Allergy to macrolides. 21 cases. Presse Med.29, 294–298 (2000).
   Google Scholar
• Ulrich G, Schmutz JL, Trechot PH, Commun N, Barbaud A. Sensitization to petrolatum: an unusual cause of false positive drug patch tests. Allergy59, 1006–1009 (2004).
   Google Scholar